Drugs News and Research

RSS

Findings expand treatment options for hormone-dependent breast cancer

According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.

5 Feb 2014

Study shows similarities in pathogenesis of neurological diseases and HIV virus

A new study by George Washington University (GW) researcher Michael Bukrinsky, M.D., Ph.D., shows similarities in the pathogenesis of prion disease — misfolded proteins that can lead to neurological diseases — and the HIV virus.

5 Feb 2014

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to standard antiepileptic drugs.

5 Feb 2014

New drug treatment effective against chronic pain caused by nerve damage post shingles

A new drug treatment has been found to be effective against chronic pain caused by nerve damage, also known as neuropathic pain, in patients who have had shingles.

5 Feb 2014

Randomized trial shows injecting anesthetic near nerve bundle reduces troublesome hot flashes

Injecting a little anesthetic near a nerve bundle in the neck cut troublesome hot flashes significantly, shows a new randomized, controlled trial published online today in Menopause, the journal of The North American Menopause Society (NAMS).

5 Feb 2014

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

5 Feb 2014

Adolescent consumption of energy drink is strongly associated with substance use, says study

Nearly one-third of US adolescents consume high-caffeine energy drinks or "shots," and these teens report higher rates of alcohol, cigarette, or drug use, reports a study in the January/February Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Feb 2014

Alabama experts develop living document that includes new therapies for Hepatitis C virus

When treatment guidelines for a particular disease emerge, they are often published in a peer-reviewed medical journal, which can take up to three years. One University of Alabama at Birmingham infectious diseases expert recently helped develop new Hepatitis C virus (HCV) guidelines that can be updated and published as new data emerge and new therapies are approved.

5 Feb 2014

New study correlates brain activity with how people make decisions when they engage in risky behavior

A new study correlating brain activity with how people make decisions suggests that when individuals engage in risky behavior, such as drunk driving or unsafe sex, it's probably not because their brains' desire systems are too active, but because their self-control systems are not active enough.

5 Feb 2014

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.

4 Feb 2014

First Edition: February 4, 2014

Today's headlines include progress reports on health exchanges in Washington state and New York as well as poll results on Virginia's Medicaid Expansion.

4 Feb 2014

NeuroRehabilitation showcases different approaches to restoring mental functioning

There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related cognitive decline.

4 Feb 2014

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.

4 Feb 2014

Researchers discover genetic mutations that cause deadly lung disease

A team of researchers, led by physicians and scientists at Intermountain Medical Center and ARUP Laboratories in Salt Lake City, has made a medical breakthrough by discovering genetic mutations that cause a rare and deadly lung disease.

4 Feb 2014

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.

4 Feb 2014

Drugs News and Research

Findings expand treatment options for hormone-dependent breast cancer

Study shows similarities in pathogenesis of neurological diseases and HIV virus

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

New drug treatment effective against chronic pain caused by nerve damage post shingles

Randomized trial shows injecting anesthetic near nerve bundle reduces troublesome hot flashes

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Adolescent consumption of energy drink is strongly associated with substance use, says study

Alabama experts develop living document that includes new therapies for Hepatitis C virus

New study correlates brain activity with how people make decisions when they engage in risky behavior

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

First Edition: February 4, 2014

NeuroRehabilitation showcases different approaches to restoring mental functioning

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Researchers discover genetic mutations that cause deadly lung disease

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

Drug used to treat schizophrenia, dementia has potential for treating liver disease

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Study focuses on development and spread of Alzheimer's disease throughout the brain

Research: SSeCKS/AKAP12 gene key inhibitor of prostate cancer metastasis

Selcia, University of Edinburgh collaborate to develop novel treatments for sleeping sickness

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News